Pharma Facebook Fallout

Posted by: in Healthcare Insights, Medical Communications on August 23, 2011

All alliteration aside, many pharmaceutical clients have been on pins and needles over the past week, as Facebook opened up user commenting on their Facebook Pages. It seems last week came and went with very little to-do. The world kept spinning, the sun still rose, and the stock markets didn’t … forget that last one.

One question that’s been on everyone’s mind is, “Who did what?” People have been curious to know who took their Pages down, are they allowing comments, have they implemented a policy? Jonathan Richman’s Dose of Digital created a great post that outlined which Pages stayed and which ones didn’t. We decided to take that to the next level to answer some of the above questions.

On this Google Docs spreadsheet, we’ve outlined what certain companies have done with their Facebook Pages after August 15. You’ll see that only 10 of the 62 Pages shown have actually gone away. A great sign that these companies are committed to social media! If you see that any Pages have updated in the meantime, feel free to leave a comment here, and we’ll update the spreadsheet.

Pharma Facebook Pages

By: Matthew Snodgrass

Group Director of Digital Strategy at NextWorks, partner of The W2O Group.

Find me on: Twitter Facebook
Pre-Commerce Check out W2O Group President Bob Pearson's new book, Pre-Commerce, in which he shares ideas for leaders to engage directly with customers to shape their brand and marketplace success. Now available for order on Amazon.com! http://amzn.to/bAmvFN. Join the conversation #precommerce.

2 Responses

Stay in touch with the conversation, subscribe to the RSS feed for comments on this post.

  1. Thanks for the post Matthew, people are paying a lot more of attention to websites and play an active role in patrolling various companies’ activities via the internet. I think that social media has become a must have for companies to have in this day and age. In particular, Facebook is the most recognizable and most exploited site on the world wide web. I feel that it would be crazy for companies to start taking down pages after creating them, it only raises questions about that company’s credibility. Then, raises questions about their view of us, the consumer, and our best interest.

Continuing the Discussion

  1. Reflections on an Abyss – the Facebook Policy Change | Eye on FDA linked to this post on September 7, 2011

    [...] resulted in much of a stir at all, per this Spreadsheet put together by Matthew Snodgrass at the CommonSense blog premised on the nice research and tracking by Jonathan Richman at Dose of [...]

Some HTML is OK

(required)

(required, but never shared)

or, reply to this post via trackback.